Eupraxia Pharmaceuticals Inc.
EPRXF · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $32 | $49 | $19 | $33 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $0 | $0 | $0 |
| Total Curr. Assets | $34 | $49 | $20 | $34 |
| Property Plant & Equip (Net) | $1 | $1 | $0 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $1 | $1 | $0 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $34 | $50 | $20 | $34 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $0 |
| Short-Term Debt | $6 | $13 | $10 | $15 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $10 | $12 | $9 | $4 |
| Total Curr. Liab. | $16 | $25 | $19 | $19 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $16 | $25 | $19 | $19 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $159 | $157 | $93 | $118 |
| Retained Earnings | -$161 | -$151 | -$106 | -$123 |
| AOCI | -$4 | -$4 | -$3 | $0 |
| Other Equity | $185 | $24 | $18 | $22 |
| Total Equity | $20 | $26 | $2 | $17 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$2 | -$2 | -$1 | -$2 |
| Total Liab. & Tot. Equity | $34 | $50 | $20 | $34 |
| Net Debt | -$26 | -$36 | -$9 | -$18 |